← Leaderboards
Alex Kayongo
Makerere University College Of Health Sciences
$697,599
Attributed
$697,599
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $423.1K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$697,599 · 2
By mechanism
R21$573,075 · 1
K43$124,524 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Immune”
- Angee Greer · Ppd Development Lp$82,531,927
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Jason Dickens · Duke University$12,259,409
- Suma Babu · Massachusetts General Hospital$11,004,714
Research focus
ImmuneCohortChronic Obstructive Pulmonary DiseaseRuralPersonsUgandaSamplingAirway InflammationMortalityMediatingMorbidity - Disease RateAntiretroviral TherapyPrevalenceParticipantLongevityInflammatoryLungChronicInflammationCytokineDistalBronchoscopyAfrica South Of The SaharaBronchoalveolar Lavage
Grant awards (5)
Clonotyping Airway T-cells to Uncover Microbiome-Specific Inflammotypes in HIV-associated COPD$124,524
K43 · FY2025 · TW · contact PI
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual$199,955
R21 · FY2023 · TW · contact PI
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual$123,120
R21 · FY2023 · TW · contact PI
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual$100,000
R21 · FY2023 · TW · contact PI
Investigating the role of altered lung microbiome in fueling Th17 mediated airway inflammation in COPD among HIV-infected individual$150,000
R21 · FY2022 · TW · contact PI